AHG:NSD-Akso Health Group ADR (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 1.14

Change

0.00 (0.00)%

Market Cap

USD 0.17B

Volume

0.29M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-06 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
HSIC Henry Schein Inc

+0.02 (+0.03%)

USD 9.28B
PDCO Patterson Companies Inc

+0.37 (+1.83%)

USD 1.95B
EDAP EDAP TMS SA

+0.06 (+2.33%)

USD 0.10B
YI 111 Inc

+0.15 (+16.67%)

USD 0.07B
COSM Cosmos Health Inc.

+0.04 (+5.39%)

N/A
ZYXI Zynex Inc

+0.07 (+0.89%)

N/A

ETFs Containing AHG

OFOS Exchange Traded Concepts .. 3.45 % 0.00 %

+0.28 (+1.10%)

USD 8.59M

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 54.05% 100% F 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.05% 100% F 92% A
Trailing 12 Months  
Capital Gain 235.29% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 235.29% 100% F 99% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 34.10% 100% F 87% B+
Dividend Return 34.10% 100% F 86% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 106.27% 14% F 14% F
Risk Adjusted Return 32.08% 71% C- 65% D
Market Capitalization 0.17B 43% F 46% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector